HEMOGLOBIN PONTOISE ALPHA 63 ALA->ASP (E12). A NEW FAST MOVING VARIANT.THILLET J; BLOUQUIT Y; PERRONE F et al.1977; BIOCHIM. BIOPHYS. ACTA; PAYS-BAS; DA. 1977; VOL. 491; NO 1; PP. 16-22; BIBL. 21 REF.Article

Carboplatin and Pegylated Liposomal Doxorubicin for Advanced Ovarian Cancer : Preliminary Activity Results of the MITO-2 Phase III TrialPIGNATA, S; SCAMBIA, G; SCOLLO, P et al.Oncology. 2009, Vol 76, Num 1, pp 49-54, issn 0030-2414, 6 p.Article

Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)DEL MASTRO, L; PERRONE, F; CATZEDDU, T et al.Annals of oncology. 2005, Vol 16, Num 2, pp 253-258, issn 0923-7534, 6 p.Article

Experimental dosimetry of a ³²P catheter-based endovascular brachytherapy sourcePIERMATTEI, A; FIDANZIO, A; PERRONE, F et al.Physics in medicine & biology (Print). 2003, Vol 48, Num 15, pp 2283-2296, issn 0031-9155, 14 p.Article

Carboplatin plus paclitaxel in extensive small cell lung cancer : A multicentre phase 2 studyGRIDELLI, C; MANZIONE, L; BILANCIA, D et al.British journal of cancer. 2001, Vol 84, Num 1, pp 38-41, issn 0007-0920Article

Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trialDANIELE, B; PERRONE, F; GALLO, C et al.Gut. 2001, Vol 48, Num 1, pp 28-33, issn 0017-5749Article

The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancerDE PLACIDO, S; LAURIA, R; BIANCO, A. R et al.International journal of oncology. 1999, Vol 15, Num 2, pp 339-346, issn 1019-6439Article

Phase ii study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervixPIGNATA, S; SILVESTRO, G; CORMIO, G et al.Journal of clinical oncology. 1999, Vol 17, Num 3, pp 756-760, issn 0732-183XArticle

Are platinum compounds mandatory in the treatment of metastatic non-small cell lung cancer?RUCKDESCHEL, J. C; GRIDELLI, C; PERRONE, F et al.European journal of cancer (1990). 1998, Vol 34, Num 13, pp 1993-1999, issn 0959-8049Article

Prognostic significance of necrosis, elastosis, fibrosis and inflammatory cell reaction in operable breast cancerCARLOMAGNO, C; PERRONE, F; PETRELLA, G et al.Oncology. 1995, Vol 52, Num 4, pp 272-277, issn 0030-2414Article

The prognostic value of lymphatic and blood vessel invasion in operable breast cancerLAURIA, R; PERRONE, F; BIANCO, A. R et al.Cancer. 1995, Vol 76, Num 10, pp 1772-1778, issn 0008-543XArticle

Informed versus randomised consent to clinical trialsGALLO, C; PERRONE, F; DE PLACIDO, S et al.Lancet (British edition). 1995, Vol 346, Num 8982, pp 1060-1064, issn 0140-6736Article

Combination of nicotinamide and steroid versus nicotinamide in recent-oncent IDDM : the IMDIAB II studyPOZZILLI, P; VISALLI, N; MATTEOLI, M. C et al.Diabetes care. 1994, Vol 17, Num 8, pp 897-900, issn 0149-5992Article

Mitomycin C and mitoxantrone in anthracycline-pretreated advanced breast cancer patients : a phase II studyPERRONE, F; DE PLACIDO, S; CARLOMAGNO, C et al.American journal of clinical oncology. 1994, Vol 17, Num 3, pp 218-222, issn 0277-3732Article

Limits on the violation of g-universality with a Galileo-type experimentCARUSOTTO, S; CAVASINNI, V; MORDACCI, A et al.Physics letters. A. 1993, Vol 183, Num 5-6, pp 355-358, issn 0375-9601Article

Diminution de la triiodothyronine et de sa forme inverse sous l'effet de l'épuration extra-rénale: rôle de l'apport glucidique = Decrease in triiodothyronine and its reverse form under dialysis: role of carbohydrate intakeVERGER, M. F; VERGER, C; MERCIER-HATT, D et al.La Presse médicale (1983). 1984, Vol 13, Num 26, pp 1613-1616, issn 0755-4982Article

Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancerZANUTTO, S; PIZZAMIGLIO, S; PIEROTTI, M. A et al.British journal of cancer. 2014, Vol 110, Num 4, pp 1001-1007, issn 0007-0920, 7 p.Article

Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation studyGRANATA, R; MICELI, R; MARIANI, L et al.Annals of oncology. 2012, Vol 23, Num 7, pp 1832-1837, issn 0923-7534, 6 p.Article

Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II studyLOCATI, L. D; BOSSI, P; LIBERATOSCIOLI, C et al.Oral oncology (1997). 2009, Vol 45, Num 7, pp 574-578, issn 1368-8375, 5 p.Article

Biology, prognosis and response to therapy of breast carcinomas according to HER2 scoreMENARD, S; BALSARI, A; QUERZOLI, P et al.Annals of oncology. 2008, Vol 19, Num 10, pp 1706-1712, issn 0923-7534, 7 p.Article

Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trialPACILIO, C; MORABITO, A; BOTTI, G et al.British journal of cancer. 2006, Vol 94, Num 9, pp 1233-1236, issn 0007-0920, 4 p.Article

Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer : The IGCS-COL multicentre, randomised, phase III studyDE PLACIDO, S; LOPEZ, M; FARRIS, A et al.British journal of cancer. 2005, Vol 93, Num 8, pp 896-904, issn 0007-0920, 9 p.Article

Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trialPERRONE, F; GALLO, C; PIAI, G et al.Current pharmaceutical design. 2002, Vol 8, Num 11, pp 1013-1019, issn 1381-6128Article

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome : A randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluationMOGHETTI, P; CASTELLO, R; NEGRI, C et al.The Journal of clinical endocrinology and metabolism. 2000, Vol 85, Num 1, pp 139-146, issn 0021-972XArticle

Pathobiologic identification of two distinct breast carcinoma subsets with diverging clinical behaviorsMENARD, S; CASALINI, P; TOMASIC, G et al.Breast cancer research and treatment. 1999, Vol 55, Num 2, pp 169-177, issn 0167-6806Article